Abstract
GLP-1 agonists are novel medications. Its relationship with the decrease in gastric motility is clear; this presents a challenge when performing an induction under general anesthesia. Therefore, knowing its pharmacokinetics and the current recommendations described by the American Society Anesthesiologists (ASA) to evaluate perioperative risk during elective surgery are important. The objective is to review pharmacokinetics of GLP-1 analogues and evaluate current recommendations for perioperative management in patients undergoing elective surgery. We searched for articles using the keywords and medical topic titles: incretins; glucagon-like peptide-1; GLP-1; glucagon-like peptide 1 receptor agonists; GLP-1 RA; perioperative period; perioperative; perioperative; stomach emptying; gastric emptying; pulmonary aspiration; aspiration of gastric content; regurgitation of food; and regurgitation. The evidence was analyzed, synthesized and reported narratively. The elimination half-life of GLP-1 agonists determines the suspension time prior to the surgical procedure. Gastric ultrasound is a potentially quantitative tool to evaluate gastric contents prior to elective surgery.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.